Originally launched in 2006, the World Cancer Declaration has helped to bring the growing cancer crisis to the attention of government leaders and health policy-makers. Dr Julie Torode and Rebecca Morton Doherty of UICC explains how by more closely aligning the updated World Cancer Declaration with the emerging global NCD framework and post-2015 development discourse, the Declaration targets resonate more widely, allowing the cancer community to reach out to non-traditional partners in the development, disability, education, employment and many other sectors, for innovative partnership.
https://international-pharma.com/wp-content/uploads/2014/03/Realising-peak…pdf1.pdf
Current Edition
Current Edition
Subsection - CDMO
Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.
Continue readingSubsection - Injectables
Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.
Continue readingSubsection - Neurodegenerative Diseases
Exploring emerging approaches to neurodegenerative disease research and treatment.
Continue readingSubsection - Nasal & Pulmonary
Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.
Continue reading
Scaling up Action to Meet the New World Cancer Declaration Targets
